The document discusses agomelatine, a novel antidepressant with melatonergic and serotonergic properties. It summarizes agomelatine's mechanism of action, clinical effects in treating depression and anxiety, indications, efficacy and tolerability profile compared to other antidepressants. Some key advantages are its well-tolerability, lack of sexual side effects, weight gain and discontinuation syndrome. However, liver function tests need monitoring and its efficacy may be modest for severe depression requiring combination therapy. The recommended dosing is 25mg once daily increased to 50mg if no response after two weeks.